Distribution of genotypes determined by CCG or Δ2642 glutamic acid polymorphisms in controls and patients with Huntington’s disease
| Genotype | Control group | HD group | p Value overall | ||||||
|---|---|---|---|---|---|---|---|---|---|
| n | % | n | % | ||||||
| CCG 7/7 | 19 | 27.9 | 51 | 60.7 | |||||
| CCG 7/8 | 2 | 3.1 | 2 | 2.4 | |||||
| CCG 7/9 | 5 | 7.3 | 2 | 2.4 | |||||
| CCG 7/10 | 37 | 54.4 | 28 | 33.3 | |||||
| CCG 10/10 | 5 | 7.3 | 1 | 1.2 | |||||
| Total | 68 | 100 | 84 | 100 | <0.005 | ||||
| A/A | 57 | 83.8 | 46 | 54.8 | |||||
| A/B | 11 | 16.2 | 34 | 40.5 | |||||
| B/B | 0 | 0 | 4 | 4.7 | |||||
| Total | 68 | 100 | 84 | 100 | <0.001 | ||||